Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION AND EMPLOYEE BENEFIT PLANS - 2021 Equity Plan (Details)

v3.24.0.1
SHARE-BASED COMPENSATION AND EMPLOYEE BENEFIT PLANS - 2021 Equity Plan (Details) - USD ($)
 1 Months Ended 2 Months Ended 10 Months Ended 12 Months Ended
May 08, 2023
May 07, 2023
Mar. 08, 2023
Dec. 07, 2021
Mar. 31, 2023
Dec. 31, 2021
Nov. 08, 2021
Dec. 31, 2023
Dec. 31, 2022
Nov. 09, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares authorized and reserved for future issuance (in shares)                   31,900,000
Lower exercise price (in usd per share)               $ 2.94    
Upper exercise price (in usd per share)               $ 14.00    
Granted (in shares)               2,580,000    
Options outstanding (in shares)               11,244,171 10,339,171  
Period to comply with minimum personal investment requirement               5 years    
Noncash stock compensation expense           $ 4,821,000 $ 156,000 $ 1,596,000 $ 14,649,000  
Unrecognized compensation expense               15,600,000    
Compensation expense recognized           4,821,000 $ 156,000 1,596,000 14,649,000  
Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Minimum personal investment requirement               2,200,000    
Director                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Minimum personal investment requirement               $ 1,500,000    
Stock Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Expiration period               10 years    
Noncash stock compensation expense           3,600,000   $ 1,600,000 14,600,000  
Tax benefit recognized           300,000   $ 800,000 $ 1,500,000  
Period for recognition               2 years 1 month 6 days    
Bridge Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares)               245,004    
Target EBITDA               $ 136,000,000    
5-Year Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares)               10,999,167    
Stock Option, Eligible For Vesting Based On Five Year Performance                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting period     5 years   5 years     5 years    
Annual operation performance per diluted share (in usd per share)         $ 8.39          
Target annual operation performance per diluted share (in usd per share)         $ 11.35          
Cancelled (in shares)         240,000          
Look-back period 2 years                  
Look-forward period 2 years                  
Minimum compounded annual growth 10.00% 13.50%                
Maximum compounded annual growth 20.00% 23.50%                
Incremental expense               $ 0    
Stock Option, Eligible For Vesting Based On Five Year Performance | Former Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Performance and time based vesting percentage     50.00%              
Performance based vesting percentage     50.00%              
Pre Modification 2023 Option Grants                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Options outstanding (in shares)               2,175,000    
Post Modification 2023 Option Grants                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Options outstanding (in shares)               405,000    
Ordinary Shares | Consultant                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Awards granted in period (in shares)       100,000            
Grant date fair value (in usd per share)       $ 11.75            
Compensation expense recognized           $ 1,200,000